Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
1/18/18 PharmaMar (ZEL:SM) Zepsyre for Ovarian Cancer Subscribers Only Subscribers Only Subscribers Only
1/18/18 Amgen (AMGN) Mvasi for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
1/18/18 Aquestive AQST-120 for Lennox-Gastaut Syndrome (LGS; Epilepsy) Subscribers Only Subscribers Only Subscribers Only
1/17/18 Evofem (EVFM) Amphora for Contraception Subscribers Only Subscribers Only Subscribers Only
1/17/18 Novartis (NVS) Kymriah for Diffuse Large B-Cell Lymphoma (DLBCL) - NHL Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
Now - 01/19/18 Subscribers Only Subscribers Only Partnership - Acquisition Completion
Now - 01/19/18 Subscribers Only Subscribers Only Partnership - Acquisition Completion
01/19/18 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
01/19/18 Subscribers Only Subscribers Only Trial Data - Top-Line Results
01/19/18 Subscribers Only Subscribers Only Trial Data - Updated Results
Back to the top Back to the top